应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NMRA Neumora Therapeutics, Inc.
已收盘 07-22 16:00:00 EDT
11.61
+0.33
+2.93%
盘后
11.61
+0.00
0.00%
16:20 EDT
最高
11.92
最低
11.33
成交量
58.98万
今开
11.77
昨收
11.28
日振幅
5.23%
总市值
18.52亿
流通市值
9.61亿
总股本
1.60亿
成交额
684.50万
换手率
0.71%
流通股本
8,280万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
美国研究综述-阿里斯塔网络公司、新月能源公司、戴尔科技公司
Reuters · 05-20
美国研究综述-阿里斯塔网络公司、新月能源公司、戴尔科技公司
嗡嗡声--美国股票走势-思科系统公司、灵感娱乐公司、精神航空公司
Reuters · 04-16
嗡嗡声--美国股票走势-思科系统公司、灵感娱乐公司、精神航空公司
嗡嗡声--美国股票走势-Encore Wire、Masimo、高盛集团
Reuters · 04-15
嗡嗡声--美国股票走势-Encore Wire、Masimo、高盛集团
嗡嗡声--美国股票走势-Longeveron、Novavax、Telsa
Reuters · 04-15
嗡嗡声--美国股票走势-Longeveron、Novavax、Telsa
BUZZ-Neumora Therapeutics 因美国 FDA 搁置精神分裂症药物研究而下跌
Reuters · 04-15
BUZZ-Neumora Therapeutics 因美国 FDA 搁置精神分裂症药物研究而下跌
更新版 1-Neumora公司的早期精神分裂症药物研究被搁置
Reuters · 04-15
更新版 1-Neumora公司的早期精神分裂症药物研究被搁置
美国研究综述-Lennar, Republic Services, Ulta Beauty
Reuters · 03-18
美国研究综述-Lennar, Republic Services, Ulta Beauty
公司概况
公司名称:
Neumora Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Neumora Therapeutics, Inc.成立于2019年11月,当时是一家特拉华州公司,名称为RBNC Therapeutics, Inc.。该公司于2021年10月更名为Neumora Therapeutics, Inc.。该公司是一家临床阶段的生物制药公司,旨在应对全球脑部疾病危机,对脑部疾病的治疗方法采取一种根本不同的方法。该公司的治疗管道规模迅速扩大,目前包括七个临床和临床前神经科学项目,针对广泛的未得到充分服务的神经精神疾病和神经退行性疾病的新的作用机制。该公司最先进的候选产品navacaprant(NMRA-140)是一种新型的每日一次口服kappa阿片受体(KOR)拮抗剂,正在开发用于治疗重度抑郁症(MDD),他们认为,如果获得批准,这种药物有可能提供相对于标准护理的显著优势。
发行价格:
--
{"stockData":{"symbol":"NMRA","market":"US","secType":"STK","nameCN":"Neumora Therapeutics, Inc.","latestPrice":11.61,"timestamp":1721678400000,"preClose":11.28,"halted":0,"volume":589774,"hourTrading":{"tag":"盘后","latestPrice":11.61,"preClose":11.61,"latestTime":"16:20 EDT","volume":23912,"amount":277617.87,"timestamp":1721679600921},"delay":0,"floatShares":82803195,"shares":159523997,"eps":-2.61372,"marketStatus":"已收盘","marketStatusCode":5,"change":0.33,"latestTime":"07-22 16:00:00 EDT","open":11.77,"high":11.92,"low":11.33,"amount":6845018.485128,"amplitude":0.052305,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.61372,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721721600000},"adr":0,"listingDate":1694750400000,"adjPreClose":11.28,"preHourTrading":{"tag":"盘前","latestPrice":11.77,"preClose":11.28,"latestTime":"09:29 EDT","volume":912,"amount":10726.440575999999,"timestamp":1721654999999},"postHourTrading":{"tag":"盘后","latestPrice":11.61,"preClose":11.61,"latestTime":"16:20 EDT","volume":23912,"amount":277617.87,"timestamp":1721679600921},"volumeRatio":0.910067,"impliedVol":0.8907,"impliedVolPercentile":0.233},"requestUrl":"/m/hq/s/NMRA/wiki","defaultTab":"wiki","newsList":[{"id":"2436612841","title":"美国研究综述-阿里斯塔网络公司、新月能源公司、戴尔科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2436612841","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436612841?lang=zh_cn&edition=full","pubTime":"2024-05-20 14:56","pubTimestamp":1716188173,"startTime":"0","endTime":"0","summary":" 路透5月20日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括 Arista Networks、Crescent Energy 和戴尔科技。* 戴尔科技公司 :摩根大通将目标价从125美元上调至155美元 * Loar Holdings Inc :加拿大皇家银行给予 \"跑赢大盘 \"评级;目标价60美元 * Regeneron Pharmaceuticals Inc :Jefferies将其目标价从1,060美元上调至1,115美元。* 安特罗资源公司 :Gerdes Energy Research将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LITE","FTRE","BK4551","AR","BK4559","IE00BMPRXR70.SGD","IIPR","BK4170","LU1917777945.USD","LU2106854487.HKD","SNOW","BK4588","LOAR","BK4177","BK4139","PRMW","EWTX","LU0109392836.USD","BK4581","DAR","BHVN","LU2023250504.SGD","BK4020","LU1974910355.USD","KGS","BK4212","BK4503","LU0109394709.USD","BK4121","BK4007","BK4182","LU0289739699.SGD","BK4505","LU0289739343.SGD","FLO","NMRA","IE00BMPRXN33.USD","ANET","HCAT","CRGY","LU1803068979.SGD","AZZ","LU0114720955.EUR","BK4213","LU0289961442.SGD","REGN","BK4515","DELL","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2427883713","title":"嗡嗡声--美国股票走势-思科系统公司、灵感娱乐公司、精神航空公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2427883713","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427883713?lang=zh_cn&edition=full","pubTime":"2024-04-16 00:14","pubTimestamp":1713197647,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 4月15日 - 周一,受高盛强劲上涨的提振,道指涨幅超过华尔街同行,而零售销售数据强于预期后国债收益率的上升抑制了涨幅。美东时间11:34,道琼斯工业平均指数 上涨0.36%,报38,119.77点。标准普尔500指数 上涨0.26%,报5,136.92点;纳斯达克综合指数 上涨0.07%,报16,187.084点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASTR","LU0795875086.SGD","WBA","DVA","BK4541","BK4534","MYGN","LU1548497426.USD","SILK","BK4548","PLUG","BLKB","HUM",".DJI","PLL","SNA","SNPO","DOG","DXD","INSE","NVAX","PCAR","SDOW","LLY","HUBS","LU0234570918.USD","TXN","DDM","AAPL","ALLY","BK4532","LMT","BK4533","LU0456854461.SGD","DJX",".SPX","UDOW","NMRA","TSLA","SAVE","ANET","SNX",".IXIC","SG9999002521.SGD","NOG","TPST","XOM","CSCO"],"gpt_icon":0},{"id":"2427900599","title":"嗡嗡声--美国股票走势-Encore Wire、Masimo、高盛集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2427900599","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427900599?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:26","pubTimestamp":1713187579,"startTime":"0","endTime":"0","summary":"因Clearlake Capital提高收购报价而上涨 ** Encore Wire :盘前上涨9.0%因普睿司曼提出41.5亿美元的收购要约而上涨 ** Masimo Corp :盘前上涨4.8%Stifel将其评级上调至 \"买入\",因其计划分拆消费业务 ** 高盛 :盘前上涨3.9%因投资银行业务强劲,利润飙升28%后上涨 ** Marinus :盘前下跌74.2%因癫痫发作药物未能达到研究提前停止标准而下挫 ** Organovo Holdings :盘前上涨61.4%因脂肪肝药物在中期研究中达到主要目标而上涨 ** Trump Media & Technology :盘前下跌13.6%在提交股票备案后跳水","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0466842654.USD","LU0353189680.USD","LU1429558221.USD","IE00BJJMRX11.SGD","LU0820561818.USD","LU0943347566.SGD","AAPL","BK4532","IE00B775SV38.USD","LU1861559042.SGD","IE00B1XK9C88.USD","IE0004445239.USD","BK4511","LU1435385759.SGD","IE0009356076.USD","PCAR","SNPO","NMRA","PLL","BK4515","BK4539","BK4099","LMT","LU0097036916.USD","LU2326559502.SGD","LU2357305700.SGD","LU1914381329.SGD","LU0289739343.SGD","LU2087621335.USD","BK4534","NVAX","IE00BJJMRY28.SGD","BK4516","BLKB","IE00B3S45H60.SGD","IE00BJTD4V19.USD","LU0011850046.USD","IE0004445015.USD","BK4512","IE00BKVL7J92.USD","LU0289961442.SGD","LU1551013425.SGD","TSLA","IE00B1BXHZ80.USD","BK4007","BK4149","IE00B19Z9505.USD","LU0170899867.USD","BK4533","LU2602419157.SGD"],"gpt_icon":0},{"id":"2427071726","title":"嗡嗡声--美国股票走势-Longeveron、Novavax、Telsa","url":"https://stock-news.laohu8.com/highlight/detail?id=2427071726","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427071726?lang=zh_cn&edition=full","pubTime":"2024-04-15 19:47","pubTimestamp":1713181664,"startTime":"0","endTime":"0","summary":" 4月15日 - 周一,美国股指期货上涨,此前由于美国一些大银行的盈利令人失望,华尔街在上一交易日出现了严重的抛售,而中东地区不断升级的紧张局势也令投资者保持警惕。标准普尔500指数小型股 上涨0.49%,报5,192.75点;纳斯达克100指数小型股 上涨0.55%,报18,279.25点。因获得北卡罗来纳州项目许可而上涨 ** Neumora Therapeutics :盘前下跌 13.7 因美国 FDA 暂停精神分裂症药物研究而下跌 ** Blackbaud :盘前上涨2.7%。因Clearlake Capital提高收购报价而上涨","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0072462426.USD","LU1244550577.SGD","NXPL","LU0417517546.SGD","LU0308772762.SGD","BK4089","BK4516","BK4534","LU1162221912.USD","LMT","LU1852331112.SGD","BK4553","AAPL","BK4554","IE00BZ1G4Q59.USD","LU0316494557.USD","LGVN","BK4510","PRPL","IE00BLSP4239.USD","BK4555","BK4548","IE00BWXC8680.SGD","IE0009356076.USD","BK4511","BK4532","MOH","MRNS","BK4550","IE00B7KXQ091.USD","BK4512","IE00BBT3K403.USD","IE00B19Z9505.USD","PLL","BK4539","BK4533","BK4095","BLKB","LU0238689110.USD","PCAR","TSLA","NVAX","SNPO","SG9999014005.SGD","BK4559","REZI","NMRA","KUKE","LU1861220033.SGD","MPW"],"gpt_icon":0},{"id":"2427076705","title":"BUZZ-Neumora Therapeutics 因美国 FDA 搁置精神分裂症药物研究而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2427076705","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427076705?lang=zh_cn&edition=full","pubTime":"2024-04-15 19:13","pubTimestamp":1713179599,"startTime":"0","endTime":"0","summary":" 4月15日 - ** 药物开发商Neumora Therapeutics 股价盘前下跌22.5%至10.51美元 ** 该公司称 美国食品和药物管理局 已暂停其精神分裂症候选药物的早期临床研究** 精神分裂症是一种严重的精神疾病,患者会出现幻觉和妄想等与现实脱节的症状。** 最近获得的临床前数据显示,该药物在兔子体内会引起抽搐,FDA 因此暂停了该药物的临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NMRA","LENZ","BK4007","BUZZ"],"gpt_icon":0},{"id":"2427598075","title":"更新版 1-Neumora公司的早期精神分裂症药物研究被搁置","url":"https://stock-news.laohu8.com/highlight/detail?id=2427598075","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427598075?lang=zh_cn&edition=full","pubTime":"2024-04-15 18:52","pubTimestamp":1713178340,"startTime":"0","endTime":"0","summary":" 路透社4月15日 - Neumora Therapeutics 周一表示,美国食品和药物管理局 已暂停其精神分裂症实验药物的早期临床研究,这导致其股价在盘前交易中下跌超过23%。在最近获得的临床前数据显示兔子出现无法控制的肌肉收缩或抽搐后,FDA 决定暂停这项研究。该公司现已暂停了这项早期研究。该公司说,在早期阶段研究中,约有 30 名参与者服药,没有发现任何参与者出现抽搐的迹象。Neumora 正在与 FDA 合作解决临床暂停问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","LU2242652126.USD","BK4139","LU0122379950.USD","LU0109394709.USD","BK4534","AMGN","LU0868494617.USD","LU2242646821.SGD","BK4588","LU0289739699.SGD","LU0320765992.SGD","LU1057294990.SGD","SG9999001440.SGD","LU1023059063.AUD","BK4533","BK4581","BK4007","LU0058720904.USD","LU0889565916.HKD","BK4585","NMRA","BK4566"],"gpt_icon":0},{"id":"2420277410","title":"美国研究综述-Lennar, Republic Services, Ulta Beauty","url":"https://stock-news.laohu8.com/highlight/detail?id=2420277410","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420277410?lang=zh_cn&edition=full","pubTime":"2024-03-18 15:17","pubTimestamp":1710746257,"startTime":"0","endTime":"0","summary":" 路透社3月18日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括 Lennar、Republic Services 和 Ulta Beauty。要闻 * 莱纳公司 :摩根大通将目标价从161美元下调至157美元 * Republic Services Inc :杰富瑞将目标价从213美元上调至225美元 * Ulta Beauty Inc :Raymond James将目标价从575美元上调至630美元 * Waste Management Inc :杰富瑞将目标价从230美元上调至256美元 以下是路透社周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","SLDB","BK4535","LU1585245621.USD","SGXZ23171101.USD","LU2023250843.SGD","PGR","LU0321505439.SGD","BLND","BK4081","WBA","BK4107","BK4202","PHR","LU0321505868.SGD","LU1571399168.USD","LU2362540622.SGD","ULTA","NEWT","BK4184","LU1989772840.SGD","RSG","NMRA","LU0354030438.USD","LU0354030511.USD","BK4534","IE00BFSS8Q28.SGD","LU1989772923.USD","BK4088","BK4167","LU2092937221.SGD","IE00BZ1G4Q59.USD","BK4533","LEN","PTMN","AGEN","LU0823411888.USD","SGC","WM","NRG","BK4539","IE00B7KXQ091.USD","DIBS","SHCO","LU1989763690.USD","LU1989763427.SGD","BK4220","LU0289960550.SGD","KDP","BRLT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neumoratx.com","stockEarnings":[{"period":"1week","weight":0.0208},{"period":"1month","weight":0.2328},{"period":"3month","weight":0.1081},{"period":"6month","weight":-0.2084},{"period":"1year","weight":-0.3365},{"period":"ytd","weight":-0.3384}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neumora Therapeutics, Inc.成立于2019年11月,当时是一家特拉华州公司,名称为RBNC Therapeutics, Inc.。该公司于2021年10月更名为Neumora Therapeutics, Inc.。该公司是一家临床阶段的生物制药公司,旨在应对全球脑部疾病危机,对脑部疾病的治疗方法采取一种根本不同的方法。该公司的治疗管道规模迅速扩大,目前包括七个临床和临床前神经科学项目,针对广泛的未得到充分服务的神经精神疾病和神经退行性疾病的新的作用机制。该公司最先进的候选产品navacaprant(NMRA-140)是一种新型的每日一次口服kappa阿片受体(KOR)拮抗剂,正在开发用于治疗重度抑郁症(MDD),他们认为,如果获得批准,这种药物有可能提供相对于标准护理的显著优势。","exchange":"NASDAQ","name":"Neumora Therapeutics, Inc.","nameEN":"Neumora Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Neumora Therapeutics, Inc.(NMRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Neumora Therapeutics, Inc.,NMRA,Neumora Therapeutics, Inc.股票,Neumora Therapeutics, Inc.股票老虎,Neumora Therapeutics, Inc.股票老虎国际,Neumora Therapeutics, Inc.行情,Neumora Therapeutics, Inc.股票行情,Neumora Therapeutics, Inc.股价,Neumora Therapeutics, Inc.股市,Neumora Therapeutics, Inc.股票价格,Neumora Therapeutics, Inc.股票交易,Neumora Therapeutics, Inc.股票购买,Neumora Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Neumora Therapeutics, Inc.(NMRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}